KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$17.47 USD
-0.85 (-4.64%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $17.46 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
KALA 17.47 -0.85(-4.64%)
Will KALA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KALA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KALA
Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade
Zacks.com featured highlights include KALA, Graham, Arq and Hawkins
KALA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analyst Coverage Sparks Interest in These 4 Stocks Amid Volatility
KALA BIO (KALA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
KALA BIO (KALA) Moves to Strong Buy: Rationale Behind the Upgrade
Other News for KALA
PERCEPTIVE ADVISORS LLC Increases Stake in Kala Bio Inc
Shooting Star Candlestick appears for KALA after 4.83% move
KALA: HC Wainwright & Co. Raises Price Target to $35. ...
Kala Pharmaceuticals price target raised to $35 from $12 at H.C. Wainwright
Kala Pharmaceuticals price target raised by $23 at H.C. Wainwright, here's why